nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B7—Epirubicin—sarcoma	0.158	0.237	CbGbCtD
Losartan—UGT1A1—Etoposide—sarcoma	0.106	0.159	CbGbCtD
Losartan—CYP1A2—Dacarbazine—sarcoma	0.0492	0.0738	CbGbCtD
Losartan—CYP3A4—Thiotepa—sarcoma	0.0465	0.0698	CbGbCtD
Losartan—ABCB1—Dactinomycin—sarcoma	0.0373	0.056	CbGbCtD
Losartan—CYP3A5—Vincristine—sarcoma	0.0353	0.053	CbGbCtD
Losartan—ABCB1—Mitoxantrone—sarcoma	0.0334	0.0501	CbGbCtD
Losartan—CYP3A5—Etoposide—sarcoma	0.0324	0.0485	CbGbCtD
Losartan—CYP2C8—Etoposide—sarcoma	0.0311	0.0467	CbGbCtD
Losartan—CYP1A2—Etoposide—sarcoma	0.0241	0.0361	CbGbCtD
Losartan—ABCB1—Vincristine—sarcoma	0.023	0.0345	CbGbCtD
Losartan—ABCB1—Etoposide—sarcoma	0.0211	0.0316	CbGbCtD
Losartan—CYP3A4—Mitoxantrone—sarcoma	0.02	0.03	CbGbCtD
Losartan—ABCB1—Doxorubicin—sarcoma	0.0144	0.0215	CbGbCtD
Losartan—SLC2A9—cartilage tissue—sarcoma	0.014	0.117	CbGeAlD
Losartan—CYP3A4—Vincristine—sarcoma	0.0138	0.0207	CbGbCtD
Losartan—CYP3A4—Etoposide—sarcoma	0.0126	0.0189	CbGbCtD
Losartan—ACE—forelimb zeugopod—sarcoma	0.00888	0.0742	CbGeAlD
Losartan—CYP3A4—Doxorubicin—sarcoma	0.00861	0.0129	CbGbCtD
Losartan—ACE—pulmonary artery—sarcoma	0.00664	0.0555	CbGeAlD
Losartan—Irbesartan—JUN—sarcoma	0.00605	1	CrCbGaD
Losartan—ACE—forelimb—sarcoma	0.00447	0.0373	CbGeAlD
Losartan—ACE—umbilical vein—sarcoma	0.00439	0.0367	CbGeAlD
Losartan—UGT2B17—liver—sarcoma	0.00422	0.0353	CbGeAlD
Losartan—ACE—hindlimb—sarcoma	0.00402	0.0336	CbGeAlD
Losartan—ACE—arm—sarcoma	0.00384	0.0321	CbGeAlD
Losartan—SLC2A9—seminal vesicle—sarcoma	0.0038	0.0318	CbGeAlD
Losartan—SLC2A9—connective tissue—sarcoma	0.00348	0.0291	CbGeAlD
Losartan—ACE—appendage—sarcoma	0.00345	0.0288	CbGeAlD
Losartan—AGTR1—endothelium—sarcoma	0.00282	0.0235	CbGeAlD
Losartan—UGT1A10—liver—sarcoma	0.00239	0.02	CbGeAlD
Losartan—SLCO1B1—mammary gland—sarcoma	0.00217	0.0181	CbGeAlD
Losartan—ACE—endothelium—sarcoma	0.00208	0.0174	CbGeAlD
Losartan—SLC2A9—testis—sarcoma	0.00198	0.0165	CbGeAlD
Losartan—SLC2A9—liver—sarcoma	0.00187	0.0156	CbGeAlD
Losartan—ALB—mammary gland—sarcoma	0.00175	0.0146	CbGeAlD
Losartan—UGT1A3—liver—sarcoma	0.00168	0.0141	CbGeAlD
Losartan—AGTR1—myometrium—sarcoma	0.00161	0.0135	CbGeAlD
Losartan—UGT1A1—hematopoietic system—sarcoma	0.00159	0.0133	CbGeAlD
Losartan—SLC2A9—lymph node—sarcoma	0.00143	0.012	CbGeAlD
Losartan—AGTR1—hematopoietic system—sarcoma	0.00138	0.0116	CbGeAlD
Losartan—AGTR1—connective tissue—sarcoma	0.00133	0.0111	CbGeAlD
Losartan—SLCO1B1—hematopoietic system—sarcoma	0.00132	0.011	CbGeAlD
Losartan—CYP2C8—mammary gland—sarcoma	0.00123	0.0103	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—sarcoma	0.00122	0.0102	CbGeAlD
Losartan—SLCO1B3—liver—sarcoma	0.00118	0.00988	CbGeAlD
Losartan—ACE—embryo—sarcoma	0.00114	0.00957	CbGeAlD
Losartan—CYP2C9—mammary gland—sarcoma	0.00109	0.00914	CbGeAlD
Losartan—ACE—seminal vesicle—sarcoma	0.00107	0.00898	CbGeAlD
Losartan—AGTR1—cardiac atrium—sarcoma	0.00105	0.00878	CbGeAlD
Losartan—UGT2B7—testis—sarcoma	0.00102	0.00854	CbGeAlD
Losartan—ACE—hematopoietic system—sarcoma	0.00102	0.00854	CbGeAlD
Losartan—ACE—connective tissue—sarcoma	0.000984	0.00822	CbGeAlD
Losartan—AGTR1—lymphoid tissue—sarcoma	0.000974	0.00814	CbGeAlD
Losartan—UGT2B7—liver—sarcoma	0.000966	0.00807	CbGeAlD
Losartan—AGTR1—tendon—sarcoma	0.000916	0.00765	CbGeAlD
Losartan—ACE—smooth muscle tissue—sarcoma	0.0009	0.00752	CbGeAlD
Losartan—CYP2C19—hematopoietic system—sarcoma	0.000859	0.00718	CbGeAlD
Losartan—UGT1A1—liver—sarcoma	0.000821	0.00687	CbGeAlD
Losartan—ACE—cardiac atrium—sarcoma	0.000776	0.00648	CbGeAlD
Losartan—AGTR1—testis—sarcoma	0.000758	0.00634	CbGeAlD
Losartan—CYP2C8—hematopoietic system—sarcoma	0.00075	0.00627	CbGeAlD
Losartan—ACE—lymphoid tissue—sarcoma	0.000719	0.00601	CbGeAlD
Losartan—AGTR1—liver—sarcoma	0.000717	0.00599	CbGeAlD
Losartan—CYP1A2—hematopoietic system—sarcoma	0.000702	0.00587	CbGeAlD
Losartan—SLCO1B1—liver—sarcoma	0.000683	0.00571	CbGeAlD
Losartan—CYP3A5—hematopoietic system—sarcoma	0.000677	0.00566	CbGeAlD
Losartan—CYP2C9—hematopoietic system—sarcoma	0.000666	0.00557	CbGeAlD
Losartan—ACE—bone marrow—sarcoma	0.000655	0.00547	CbGeAlD
Losartan—ALB—testis—sarcoma	0.000585	0.00489	CbGeAlD
Losartan—ACE—testis—sarcoma	0.00056	0.00468	CbGeAlD
Losartan—ALB—liver—sarcoma	0.000553	0.00462	CbGeAlD
Losartan—AGTR1—lymph node—sarcoma	0.00055	0.00459	CbGeAlD
Losartan—ACE—liver—sarcoma	0.000529	0.00442	CbGeAlD
Losartan—CYP3A4—hematopoietic system—sarcoma	0.000508	0.00425	CbGeAlD
Losartan—CYP2C19—liver—sarcoma	0.000445	0.00372	CbGeAlD
Losartan—ALB—lymph node—sarcoma	0.000424	0.00354	CbGeAlD
Losartan—ABCB1—myometrium—sarcoma	0.000419	0.0035	CbGeAlD
Losartan—CYP2C8—testis—sarcoma	0.000411	0.00344	CbGeAlD
Losartan—ACE—lymph node—sarcoma	0.000406	0.00339	CbGeAlD
Losartan—ABCB1—embryo—sarcoma	0.000403	0.00337	CbGeAlD
Losartan—CYP2C8—liver—sarcoma	0.000389	0.00325	CbGeAlD
Losartan—ABCB1—seminal vesicle—sarcoma	0.000378	0.00316	CbGeAlD
Losartan—CYP1A2—liver—sarcoma	0.000364	0.00304	CbGeAlD
Losartan—ABCB1—hematopoietic system—sarcoma	0.00036	0.00301	CbGeAlD
Losartan—CYP3A5—liver—sarcoma	0.000351	0.00293	CbGeAlD
Losartan—CYP2C9—liver—sarcoma	0.000345	0.00289	CbGeAlD
Losartan—Influenza—Epirubicin—sarcoma	0.000321	0.00154	CcSEcCtD
Losartan—Pruritus—Thiotepa—sarcoma	0.00032	0.00154	CcSEcCtD
Losartan—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00032	0.00154	CcSEcCtD
Losartan—Thrombocytopenia—Etoposide—sarcoma	0.000318	0.00153	CcSEcCtD
Losartan—Tachycardia—Etoposide—sarcoma	0.000317	0.00153	CcSEcCtD
Losartan—Eosinophilia—Epirubicin—sarcoma	0.000317	0.00153	CcSEcCtD
Losartan—Abdominal pain—Vincristine—sarcoma	0.000317	0.00153	CcSEcCtD
Losartan—Body temperature increased—Vincristine—sarcoma	0.000317	0.00153	CcSEcCtD
Losartan—Dry skin—Doxorubicin—sarcoma	0.000315	0.00151	CcSEcCtD
Losartan—Hyperhidrosis—Etoposide—sarcoma	0.000314	0.00151	CcSEcCtD
Losartan—Pancreatitis—Epirubicin—sarcoma	0.000314	0.00151	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—sarcoma	0.000313	0.00151	CcSEcCtD
Losartan—Angina pectoris—Epirubicin—sarcoma	0.000312	0.0015	CcSEcCtD
Losartan—Urticaria—Mitoxantrone—sarcoma	0.000311	0.0015	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—sarcoma	0.00031	0.00149	CcSEcCtD
Losartan—Anorexia—Etoposide—sarcoma	0.00031	0.00149	CcSEcCtD
Losartan—Diarrhoea—Thiotepa—sarcoma	0.00031	0.00149	CcSEcCtD
Losartan—Body temperature increased—Mitoxantrone—sarcoma	0.000309	0.00149	CcSEcCtD
Losartan—Abdominal pain—Mitoxantrone—sarcoma	0.000309	0.00149	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000309	0.00149	CcSEcCtD
Losartan—Bronchitis—Epirubicin—sarcoma	0.000308	0.00148	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—sarcoma	0.000307	0.00148	CcSEcCtD
Losartan—Hypotension—Etoposide—sarcoma	0.000304	0.00146	CcSEcCtD
Losartan—Gastritis—Doxorubicin—sarcoma	0.000304	0.00146	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—sarcoma	0.000303	0.00146	CcSEcCtD
Losartan—Dizziness—Thiotepa—sarcoma	0.000299	0.00144	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—sarcoma	0.000298	0.00143	CcSEcCtD
Losartan—Influenza—Doxorubicin—sarcoma	0.000297	0.00143	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—sarcoma	0.000296	0.00143	CcSEcCtD
Losartan—Hypersensitivity—Vincristine—sarcoma	0.000296	0.00142	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—sarcoma	0.000294	0.00141	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—sarcoma	0.000293	0.00141	CcSEcCtD
Losartan—Paraesthesia—Etoposide—sarcoma	0.000292	0.00141	CcSEcCtD
Losartan—Weight increased—Epirubicin—sarcoma	0.000292	0.0014	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—sarcoma	0.000291	0.0014	CcSEcCtD
Losartan—Dyspnoea—Etoposide—sarcoma	0.00029	0.0014	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—sarcoma	0.000289	0.00139	CcSEcCtD
Losartan—Somnolence—Etoposide—sarcoma	0.000289	0.00139	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—sarcoma	0.000289	0.00139	CcSEcCtD
Losartan—Hypersensitivity—Mitoxantrone—sarcoma	0.000288	0.00139	CcSEcCtD
Losartan—Asthenia—Vincristine—sarcoma	0.000288	0.00139	CcSEcCtD
Losartan—Vomiting—Thiotepa—sarcoma	0.000288	0.00139	CcSEcCtD
Losartan—Pneumonia—Epirubicin—sarcoma	0.000287	0.00138	CcSEcCtD
Losartan—Vomiting—Dactinomycin—sarcoma	0.000286	0.00138	CcSEcCtD
Losartan—Rash—Thiotepa—sarcoma	0.000285	0.00137	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—sarcoma	0.000285	0.00137	CcSEcCtD
Losartan—Dermatitis—Thiotepa—sarcoma	0.000285	0.00137	CcSEcCtD
Losartan—Headache—Thiotepa—sarcoma	0.000284	0.00137	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000283	0.00136	CcSEcCtD
Losartan—Rash—Dactinomycin—sarcoma	0.000283	0.00136	CcSEcCtD
Losartan—Decreased appetite—Etoposide—sarcoma	0.000283	0.00136	CcSEcCtD
Losartan—Renal failure—Epirubicin—sarcoma	0.000281	0.00135	CcSEcCtD
Losartan—Asthenia—Mitoxantrone—sarcoma	0.00028	0.00135	CcSEcCtD
Losartan—Fatigue—Etoposide—sarcoma	0.00028	0.00135	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—sarcoma	0.00028	0.00135	CcSEcCtD
Losartan—Jaundice—Epirubicin—sarcoma	0.000279	0.00134	CcSEcCtD
Losartan—Constipation—Etoposide—sarcoma	0.000278	0.00134	CcSEcCtD
Losartan—Pain—Etoposide—sarcoma	0.000278	0.00134	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—sarcoma	0.000278	0.00134	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—sarcoma	0.000278	0.00134	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000276	0.00133	CcSEcCtD
Losartan—Diarrhoea—Vincristine—sarcoma	0.000275	0.00132	CcSEcCtD
Losartan—Sweating—Epirubicin—sarcoma	0.000274	0.00132	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—sarcoma	0.000274	0.00132	CcSEcCtD
Losartan—ABCB1—uterus—sarcoma	0.000272	0.00227	CbGeAlD
Losartan—Photosensitivity reaction—Doxorubicin—sarcoma	0.000271	0.0013	CcSEcCtD
Losartan—Weight increased—Doxorubicin—sarcoma	0.00027	0.0013	CcSEcCtD
Losartan—Epistaxis—Epirubicin—sarcoma	0.00027	0.0013	CcSEcCtD
Losartan—Nausea—Thiotepa—sarcoma	0.000269	0.00129	CcSEcCtD
Losartan—Sinusitis—Epirubicin—sarcoma	0.000268	0.00129	CcSEcCtD
Losartan—Feeling abnormal—Etoposide—sarcoma	0.000268	0.00129	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—sarcoma	0.000268	0.00129	CcSEcCtD
Losartan—Diarrhoea—Mitoxantrone—sarcoma	0.000267	0.00129	CcSEcCtD
Losartan—Nausea—Dactinomycin—sarcoma	0.000267	0.00129	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—sarcoma	0.000267	0.00128	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—sarcoma	0.000266	0.00128	CcSEcCtD
Losartan—Gastrointestinal pain—Etoposide—sarcoma	0.000266	0.00128	CcSEcCtD
Losartan—Dizziness—Vincristine—sarcoma	0.000265	0.00128	CcSEcCtD
Losartan—CYP3A4—liver—sarcoma	0.000263	0.0022	CbGeAlD
Losartan—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000262	0.00126	CcSEcCtD
Losartan—Renal failure—Doxorubicin—sarcoma	0.00026	0.00125	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—sarcoma	0.000259	0.00125	CcSEcCtD
Losartan—Urticaria—Etoposide—sarcoma	0.000258	0.00124	CcSEcCtD
Losartan—Jaundice—Doxorubicin—sarcoma	0.000258	0.00124	CcSEcCtD
Losartan—Rhinitis—Epirubicin—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Body temperature increased—Etoposide—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Abdominal pain—Etoposide—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Hepatitis—Epirubicin—sarcoma	0.000257	0.00124	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—sarcoma	0.000255	0.00123	CcSEcCtD
Losartan—Vomiting—Vincristine—sarcoma	0.000255	0.00123	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—sarcoma	0.000255	0.00123	CcSEcCtD
Losartan—Sweating—Doxorubicin—sarcoma	0.000254	0.00122	CcSEcCtD
Losartan—ABCB1—lymphoid tissue—sarcoma	0.000253	0.00212	CbGeAlD
Losartan—Rash—Vincristine—sarcoma	0.000253	0.00122	CcSEcCtD
Losartan—Dermatitis—Vincristine—sarcoma	0.000253	0.00122	CcSEcCtD
Losartan—Headache—Vincristine—sarcoma	0.000251	0.00121	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—sarcoma	0.000249	0.0012	CcSEcCtD
Losartan—Vomiting—Mitoxantrone—sarcoma	0.000249	0.0012	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—sarcoma	0.000248	0.00119	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—sarcoma	0.000247	0.00119	CcSEcCtD
Losartan—Rash—Mitoxantrone—sarcoma	0.000246	0.00119	CcSEcCtD
Losartan—Dermatitis—Mitoxantrone—sarcoma	0.000246	0.00119	CcSEcCtD
Losartan—Headache—Mitoxantrone—sarcoma	0.000245	0.00118	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—sarcoma	0.000243	0.00117	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—sarcoma	0.00024	0.00115	CcSEcCtD
Losartan—Tinnitus—Epirubicin—sarcoma	0.000239	0.00115	CcSEcCtD
Losartan—Nausea—Vincristine—sarcoma	0.000238	0.00115	CcSEcCtD
Losartan—Flushing—Epirubicin—sarcoma	0.000238	0.00115	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—sarcoma	0.000238	0.00115	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—sarcoma	0.000237	0.00114	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—sarcoma	0.000236	0.00114	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—sarcoma	0.000236	0.00113	CcSEcCtD
Losartan—Asthenia—Etoposide—sarcoma	0.000233	0.00112	CcSEcCtD
Losartan—Angiopathy—Epirubicin—sarcoma	0.000233	0.00112	CcSEcCtD
Losartan—Nausea—Mitoxantrone—sarcoma	0.000232	0.00112	CcSEcCtD
Losartan—ABCB1—bone marrow—sarcoma	0.000231	0.00193	CbGeAlD
Losartan—Pruritus—Etoposide—sarcoma	0.00023	0.00111	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—sarcoma	0.000229	0.0011	CcSEcCtD
Losartan—Alopecia—Epirubicin—sarcoma	0.000227	0.00109	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—sarcoma	0.000224	0.00108	CcSEcCtD
Losartan—Erythema—Epirubicin—sarcoma	0.000223	0.00108	CcSEcCtD
Losartan—Diarrhoea—Etoposide—sarcoma	0.000222	0.00107	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—sarcoma	0.000221	0.00107	CcSEcCtD
Losartan—Flushing—Doxorubicin—sarcoma	0.00022	0.00106	CcSEcCtD
Losartan—Flatulence—Epirubicin—sarcoma	0.00022	0.00106	CcSEcCtD
Losartan—Tension—Epirubicin—sarcoma	0.000219	0.00106	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—sarcoma	0.000219	0.00105	CcSEcCtD
Losartan—Nervousness—Epirubicin—sarcoma	0.000217	0.00104	CcSEcCtD
Losartan—Back pain—Epirubicin—sarcoma	0.000216	0.00104	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—sarcoma	0.000215	0.00104	CcSEcCtD
Losartan—Dizziness—Etoposide—sarcoma	0.000215	0.00104	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—sarcoma	0.000215	0.00103	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—sarcoma	0.000212	0.00102	CcSEcCtD
Losartan—Vision blurred—Epirubicin—sarcoma	0.00021	0.00101	CcSEcCtD
Losartan—Alopecia—Doxorubicin—sarcoma	0.00021	0.00101	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—sarcoma	0.000207	0.000998	CcSEcCtD
Losartan—Vomiting—Etoposide—sarcoma	0.000207	0.000996	CcSEcCtD
Losartan—Erythema—Doxorubicin—sarcoma	0.000207	0.000995	CcSEcCtD
Losartan—Anaemia—Epirubicin—sarcoma	0.000206	0.000994	CcSEcCtD
Losartan—Agitation—Epirubicin—sarcoma	0.000205	0.000988	CcSEcCtD
Losartan—Rash—Etoposide—sarcoma	0.000205	0.000987	CcSEcCtD
Losartan—Dermatitis—Etoposide—sarcoma	0.000205	0.000986	CcSEcCtD
Losartan—Headache—Etoposide—sarcoma	0.000204	0.000981	CcSEcCtD
Losartan—Flatulence—Doxorubicin—sarcoma	0.000204	0.000981	CcSEcCtD
Losartan—Tension—Doxorubicin—sarcoma	0.000203	0.000977	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—sarcoma	0.000202	0.000975	CcSEcCtD
Losartan—Malaise—Epirubicin—sarcoma	0.000201	0.00097	CcSEcCtD
Losartan—Nervousness—Doxorubicin—sarcoma	0.000201	0.000967	CcSEcCtD
Losartan—Vertigo—Epirubicin—sarcoma	0.000201	0.000966	CcSEcCtD
Losartan—Syncope—Epirubicin—sarcoma	0.0002	0.000965	CcSEcCtD
Losartan—Leukopenia—Epirubicin—sarcoma	0.0002	0.000963	CcSEcCtD
Losartan—Back pain—Doxorubicin—sarcoma	0.0002	0.000963	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—sarcoma	0.000199	0.000957	CcSEcCtD
Losartan—Palpitations—Epirubicin—sarcoma	0.000197	0.00095	CcSEcCtD
Losartan—ABCB1—testis—sarcoma	0.000197	0.00165	CbGeAlD
Losartan—Loss of consciousness—Epirubicin—sarcoma	0.000196	0.000945	CcSEcCtD
Losartan—Cough—Epirubicin—sarcoma	0.000195	0.000939	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—sarcoma	0.000195	0.000938	CcSEcCtD
Losartan—Nausea—Etoposide—sarcoma	0.000193	0.00093	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—sarcoma	0.000192	0.000923	CcSEcCtD
Losartan—Anaemia—Doxorubicin—sarcoma	0.000191	0.00092	CcSEcCtD
Losartan—Arthralgia—Epirubicin—sarcoma	0.00019	0.000916	CcSEcCtD
Losartan—Chest pain—Epirubicin—sarcoma	0.00019	0.000916	CcSEcCtD
Losartan—Myalgia—Epirubicin—sarcoma	0.00019	0.000916	CcSEcCtD
Losartan—Agitation—Doxorubicin—sarcoma	0.00019	0.000915	CcSEcCtD
Losartan—Anxiety—Epirubicin—sarcoma	0.000189	0.000912	CcSEcCtD
Losartan—Discomfort—Epirubicin—sarcoma	0.000188	0.000905	CcSEcCtD
Losartan—Malaise—Doxorubicin—sarcoma	0.000186	0.000897	CcSEcCtD
Losartan—ABCB1—liver—sarcoma	0.000186	0.00156	CbGeAlD
Losartan—Dry mouth—Epirubicin—sarcoma	0.000186	0.000896	CcSEcCtD
Losartan—Vertigo—Doxorubicin—sarcoma	0.000186	0.000894	CcSEcCtD
Losartan—Syncope—Doxorubicin—sarcoma	0.000185	0.000892	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—sarcoma	0.000185	0.000891	CcSEcCtD
Losartan—Confusional state—Epirubicin—sarcoma	0.000184	0.000885	CcSEcCtD
Losartan—Palpitations—Doxorubicin—sarcoma	0.000183	0.000879	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—sarcoma	0.000182	0.000878	CcSEcCtD
Losartan—Oedema—Epirubicin—sarcoma	0.000182	0.000878	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—sarcoma	0.000182	0.000875	CcSEcCtD
Losartan—Infection—Epirubicin—sarcoma	0.000181	0.000872	CcSEcCtD
Losartan—Cough—Doxorubicin—sarcoma	0.00018	0.000868	CcSEcCtD
Losartan—Shock—Epirubicin—sarcoma	0.000179	0.000864	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—sarcoma	0.000179	0.000861	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—sarcoma	0.000178	0.000859	CcSEcCtD
Losartan—Tachycardia—Epirubicin—sarcoma	0.000178	0.000857	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—sarcoma	0.000176	0.000849	CcSEcCtD
Losartan—Myalgia—Doxorubicin—sarcoma	0.000176	0.000847	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—sarcoma	0.000176	0.000847	CcSEcCtD
Losartan—Chest pain—Doxorubicin—sarcoma	0.000176	0.000847	CcSEcCtD
Losartan—Anxiety—Doxorubicin—sarcoma	0.000175	0.000844	CcSEcCtD
Losartan—Discomfort—Doxorubicin—sarcoma	0.000174	0.000837	CcSEcCtD
Losartan—Anorexia—Epirubicin—sarcoma	0.000174	0.000837	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—sarcoma	0.000172	0.000829	CcSEcCtD
Losartan—Hypotension—Epirubicin—sarcoma	0.00017	0.00082	CcSEcCtD
Losartan—Confusional state—Doxorubicin—sarcoma	0.00017	0.000819	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—sarcoma	0.000169	0.000812	CcSEcCtD
Losartan—Oedema—Doxorubicin—sarcoma	0.000169	0.000812	CcSEcCtD
Losartan—Infection—Doxorubicin—sarcoma	0.000168	0.000807	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000166	0.0008	CcSEcCtD
Losartan—Shock—Doxorubicin—sarcoma	0.000166	0.000799	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—sarcoma	0.000165	0.000796	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—sarcoma	0.000165	0.000795	CcSEcCtD
Losartan—Insomnia—Epirubicin—sarcoma	0.000165	0.000794	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—sarcoma	0.000165	0.000793	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—sarcoma	0.000164	0.000788	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—sarcoma	0.000163	0.000785	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—sarcoma	0.000162	0.000783	CcSEcCtD
Losartan—Somnolence—Epirubicin—sarcoma	0.000162	0.00078	CcSEcCtD
Losartan—Anorexia—Doxorubicin—sarcoma	0.000161	0.000774	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—sarcoma	0.00016	0.000773	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—sarcoma	0.000158	0.000763	CcSEcCtD
Losartan—Hypotension—Doxorubicin—sarcoma	0.000158	0.000759	CcSEcCtD
Losartan—Fatigue—Epirubicin—sarcoma	0.000157	0.000757	CcSEcCtD
Losartan—Constipation—Epirubicin—sarcoma	0.000156	0.000751	CcSEcCtD
Losartan—Pain—Epirubicin—sarcoma	0.000156	0.000751	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000154	0.00074	CcSEcCtD
Losartan—Insomnia—Doxorubicin—sarcoma	0.000153	0.000735	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—sarcoma	0.000151	0.000729	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—sarcoma	0.00015	0.000724	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—sarcoma	0.00015	0.000723	CcSEcCtD
Losartan—Somnolence—Doxorubicin—sarcoma	0.00015	0.000722	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—sarcoma	0.000149	0.000718	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—sarcoma	0.000148	0.000715	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—sarcoma	0.000147	0.000706	CcSEcCtD
Losartan—Fatigue—Doxorubicin—sarcoma	0.000145	0.0007	CcSEcCtD
Losartan—Urticaria—Epirubicin—sarcoma	0.000145	0.000697	CcSEcCtD
Losartan—Pain—Doxorubicin—sarcoma	0.000144	0.000695	CcSEcCtD
Losartan—Constipation—Doxorubicin—sarcoma	0.000144	0.000695	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—sarcoma	0.000144	0.000694	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—sarcoma	0.000144	0.000694	CcSEcCtD
Losartan—ABCB1—lymph node—sarcoma	0.000143	0.00119	CbGeAlD
Losartan—Feeling abnormal—Doxorubicin—sarcoma	0.000139	0.000669	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—sarcoma	0.000138	0.000664	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—sarcoma	0.000134	0.000647	CcSEcCtD
Losartan—Urticaria—Doxorubicin—sarcoma	0.000134	0.000645	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—sarcoma	0.000133	0.000642	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—sarcoma	0.000133	0.000642	CcSEcCtD
Losartan—Asthenia—Epirubicin—sarcoma	0.000131	0.00063	CcSEcCtD
Losartan—Pruritus—Epirubicin—sarcoma	0.000129	0.000621	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—sarcoma	0.000125	0.000601	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—sarcoma	0.000124	0.000598	CcSEcCtD
Losartan—Asthenia—Doxorubicin—sarcoma	0.000121	0.000583	CcSEcCtD
Losartan—Dizziness—Epirubicin—sarcoma	0.000121	0.00058	CcSEcCtD
Losartan—Pruritus—Doxorubicin—sarcoma	0.000119	0.000575	CcSEcCtD
Losartan—Vomiting—Epirubicin—sarcoma	0.000116	0.000558	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—sarcoma	0.000115	0.000556	CcSEcCtD
Losartan—Rash—Epirubicin—sarcoma	0.000115	0.000553	CcSEcCtD
Losartan—Dermatitis—Epirubicin—sarcoma	0.000115	0.000553	CcSEcCtD
Losartan—Headache—Epirubicin—sarcoma	0.000114	0.00055	CcSEcCtD
Losartan—Dizziness—Doxorubicin—sarcoma	0.000112	0.000537	CcSEcCtD
Losartan—Nausea—Epirubicin—sarcoma	0.000108	0.000521	CcSEcCtD
Losartan—Vomiting—Doxorubicin—sarcoma	0.000107	0.000516	CcSEcCtD
Losartan—Rash—Doxorubicin—sarcoma	0.000106	0.000512	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—sarcoma	0.000106	0.000512	CcSEcCtD
Losartan—Headache—Doxorubicin—sarcoma	0.000106	0.000509	CcSEcCtD
Losartan—Nausea—Doxorubicin—sarcoma	0.0001	0.000482	CcSEcCtD
